Header Logo

Connection

Richard Grant to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Richard Grant has written about Hypoglycemic Agents.
Richard Grant
Connection Strength
3.502
Hypoglycemic Agents
  1. Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes. JAMA Intern Med. 2019 12 01; 179(12):1633-1641.
    View in: PubMed
    Score: 0.568
  2. Intensification of diabetes medication and risk for 30-day readmission. Diabet Med. 2013 Feb; 30(2):e56-62.
    View in: PubMed
    Score: 0.354
  3. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians. Arch Intern Med. 2012 May 28; 172(10):821-3.
    View in: PubMed
    Score: 0.337
  4. Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines. Diabetes Educ. 2011 Jan-Feb; 37(1):78-84.
    View in: PubMed
    Score: 0.304
  5. Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%. Diabetes Care. 2008 Mar; 31(3):386-90.
    View in: PubMed
    Score: 0.248
  6. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care. 2007 Jun; 30(6):1448-53.
    View in: PubMed
    Score: 0.235
  7. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007 Apr; 30(4):807-12.
    View in: PubMed
    Score: 0.233
  8. Frequent outpatient contact and decreasing medication affordability in patients with diabetes from 1997 to 2004. Diabetes Care. 2006 Jun; 29(6):1386-8.
    View in: PubMed
    Score: 0.223
  9. Should the insulin resistance syndrome be treated in the elderly? Drugs Aging. 2004; 21(3):141-51.
    View in: PubMed
    Score: 0.188
  10. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother. 2003 Jul-Aug; 37(7-8):962-9.
    View in: PubMed
    Score: 0.182
  11. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes. PLoS One. 2015; 10(3):e0121553.
    View in: PubMed
    Score: 0.103
  12. Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
    View in: PubMed
    Score: 0.102
  13. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. Metabolism. 2013 Dec; 62(12):1772-8.
    View in: PubMed
    Score: 0.092
  14. Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study. BMC Health Serv Res. 2010 Jun 09; 10:158.
    View in: PubMed
    Score: 0.074
  15. Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care. 2010 Mar; 33(3):526-31.
    View in: PubMed
    Score: 0.071
  16. Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes. Diabet Med. 2007 Jan; 24(1):48-54.
    View in: PubMed
    Score: 0.058
  17. Overcoming barriers to evidence-based diabetes care. Curr Diabetes Rev. 2006 May; 2(2):261-9.
    View in: PubMed
    Score: 0.055
  18. Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med. 2004 May 24; 164(10):1134-9.
    View in: PubMed
    Score: 0.048
  19. Medication adherence and racial differences in A1C control. Diabetes Care. 2008 May; 31(5):916-21.
    View in: PubMed
    Score: 0.016
  20. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care. 2005 Mar; 28(3):514-20.
    View in: PubMed
    Score: 0.013

© 2024 Kaiser Permanente